Samsung Bioepis Is Latest To Move Ustekinumab Into Phase III

Joins A Slew Of Other Biosimilar Developers Jostling For Position On Stelara

 
• By David Wallace
Paper people odd one out
Samsung Bioepis has joined a large Phase III crowd on ustekinumab • Source: Alamy

More from Biosimilars

More from Products